Max Brenner Is Considering Recapitalization Of Its Business

The luxury chocolate chain Max Brenner is currently dealing with an uncertain future as it is considering going into voluntary administration. This decision is being taken mainly due to the sluggish sales and rising costs which have made a tough retail climate for the company. McGrathNicol has been appointed as administrators by the Company’s Board to undertake the urgent review to propose a plan for the company to deal with the current financial problems. McGrathNicol is considering selling Max Brenner or recapitalizing the business. The company is currently having a staff of 300 and it’s headquartered in Alexandria, Sydney and the company is having 15 stores cross NSW, 12 in Queensland. The company is currently operating in Israel, the US, Japan, Singapore, Russia, and China.

According to the recent reports, there could be a political factor behind the company’s decline. As the chain began life in Israel it has suffered from criticism over its ongoing period and there have been cases of feuds with Palestine people. It is also believed that the change in the Australian’s food habits could be one of the main reasons for the company’s decline.  

In the late 1990s when Max Brenner was first opened in Australia, the Food scene was very different in Australia and the company witnessed an overwhelming welcome from the Australian people as there was a huge demand for the chocolates. In recent times, the novelty of Max Benner has largely decreased as artisanal chocolate and associated shops and cafés are everywhere and they have largely acquired the Australian market.

In January 2018, the company announced that it was planning to open seven new local stores in a year, however, on 29 June 2018, Sunstate Ceilings which is a Queensland business filed a wind-up notice against the Max Brenner. McGrathnicol is closely working with the management team of Max Brenner’s to help them solve the Max Brenner chain’s financial problems. It is also announced that all Max Brenner stores will run normally with minimum disruption and the McGrathnicol will complete its urgent review and propose its solution.

Dividend Stocks To Buy

The Income available from dividends remains attractive for many investors.

Sponsored ad by Kalkine

We take a look at the best yields on the market and assess what they say about a company’s prospect.

One Thing is certain, though, Australia interest rates are still low, making income difficult to come by and keeping the focus for many investors on high yielding stocks. Kalkine’s team of analysts bought you handpicked report for “Top 25 Dividend Stocks For 2018.”

ASX-relevant Special Reports are published year-round to provide a detailed analysis into an investing opportunity or a potential risk to your portfolio.

Click here to get your free report.


Disclaimer

The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkinemedia.com and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.

Join Our Discussion

Start discussion with value Investors for ASX Stock Market Investment and Opinion.


6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report

LEAVE A REPLY

Please enter your comment!
Please enter your name here